Cowen and Company’s Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant CPUH.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-22,800
Closed -$225K 770
2022
Q3
$225K Buy
+22,800
New +$225K 0.02% 172

Other funds holding CPUH.U

Cowen and Company's CPUH.U Position: Q4 2022 in Review

Cowen and Company sold out of Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant (CPUH.U) in Q4 2022, closing a stake of 22,800 shares — an estimated $225K sold.

Cowen and Company first reported a position in CPUH.U in Q3 2022 and held it in 1 quarter. The position peaked at $225K in Q3 2022. 13 funds tracked by Wall St. Rank hold CPUH.U as of Q4 2022.

  • Cowen and Company reported no remaining Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position as of Q4 2022 after selling out during the quarter.
  • Cowen and Company sold 22,800 Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant shares in Q4 2022, an estimated $225K.
  • Cowen and Company first reported a position in Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant in Q3 2022 and held it in 1 quarter.
  • Cowen and Company's Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position peaked at $225K in Q3 2022.
  • 13 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant as of Q4 2022.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.